NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIEHS E-317-2007-0-PCT-02 FLUORINE-SUBSTITUTED DMT-TIC COMPOUNDS AND METHODS OF USE PCT PCT PCT/US2008/075114 Abandoned
NICHD E-306-2007-0-PCT-02 Method for the Treatment of HIV/AIDS Infection Using Acyclovir in Identified Subjects PCT PCT PCT/US2008/010316 Expired
NCI E-302-2007-0-PCT-02 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS PCT PCT PCT/US2008/074864 Expired
NHLBI E-259-2007-0-PCT-02 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes" PCT PCT PCT/US2008/074856 Expired
NIEHS E-315-2008-0-US-01 Measurement Of Tristetraprolin Expression As A Molecular Biomarker Of Tumor Progression00366908 US 61/093,003 Abandoned
NCI E-302-2007-0-EP-05 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS EP National Stage 08798994.3 Abandoned
NCI E-302-2007-0-CA-04 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS CA National Stage 2698094 Abandoned
NCI E-302-2007-0-AU-03 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS AU National Stage 2008292910 Abandoned
NIAID E-310-2008-0-US-01 Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis US 61/092,710 Abandoned
NCI E-326-2007-0-US-03 Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions US National Stage 12/675,209 9234244 Issued PDF
NCI E-300-2001-0-US-04 Tumor Suppressor Gene, p28ING5 US DIV 12/198,897 8026350 Abandoned PDF
NCI E-326-2007-0-PCT-02 Development Of A Genomics Approach To Differentiating Benign From Malignant Thyroid Cancer PCT PCT PCT/US2008/010139 Expired
NEI E-056-2008-0-US-01 Use Of Retinal Pigment Epithelia-enriched MicroRNAs To Prevent Cell-differentiation, Proliferation, And Migration In Neovascular Disease And Tumor Development US 61/092,102 Abandoned
NCI E-230-2000-0-US-03 Vasostatin As Marrow Protectant US DIV 12/198,810 7812117 Abandoned PDF
NICHD E-147-1996-5-US-19 Use of Activity-Dependent Neutrophic Factor-Derived Polypeptides for Enhancing Learning And Memory US CON 12/197,986 Abandoned
NICHD E-209-2001-2-US-03 NEUROTROPHIC COMPONENTS OF THE ADNF 1 COMPLEX US CON 12/197,915 Abandoned
NCI E-104-2006-0-US-06 Cytotoxic T Lymphocyte Epitope(s) And Agonist Epitope(s) Of PAGE-4, A Novel Target For Vaccine Therapy US National Stage 12/280,534 7910692 Issued PDF
NCI E-106-2006-3-US-01 T-cell Receptors Recognizing TNF-related Apoptosis Inducing Ligand (TRAIL) And Death Receptor 4 (Dr4) Complex Particularly As Presented By Human Tumors` US CIP 12/196,833 7820174 Abandoned PDF
NCI E-086-2001-1-US-03 Peptides Of A Melanoma Antigen And Their Use In Diagnostic, Prophylactic And Therapeutic Methods US DIV 12/195,809 7749967 Expired PDF
NCI E-125-2006-2-US-05 EXTRACELLULAR MATRIX/METASTASIS MODIFIER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR US National Stage 12/280,260 Abandoned
NCI E-033-1999-0-US-05 High Speed Parallel Molecular Nucleic Acid Sequencing US CON 12/196,139 Abandoned
NIAID E-013-2006-1-US-02 Broad Spectrum Antiviral Compositions US National Stage 12/224,273 Pending
NIAID E-312-2008-0-US-01 Cell-Based Immunotherapy US 61/090,788 Abandoned
NIAAA E-060-2010-0-US-01 Hydroxybutyrate Ester And Medical Use Thereof US 61/090,751 Abandoned
NIA E-005-2008-0-PCT-02 Regulating GLP-1 and SGLT-1 in Gastrointestinal Cells PCT PCT PCT/US08/073756 Expired
NIA E-005-2008-0-EP-04 Regulating GLP-1 and SGLT-1 in Gastrointestinal Cells EP National Stage 08798295.5 Abandoned
NIDCR E-302-2008-0-US-01 Chemoprevention Of Head And Neck Squamous Cell Carcinomas US 61/090,414 Abandoned
NHLBI E-322-2007-0-GB-15 Compositions Containing Purine Nucleosides and Manganese and Their Uses GB EP 08835075.6 Issued
NHLBI E-322-2007-0-DE-14 Compositions Containing Purine Nucleosides and Manganese and Their Uses DE EP 08835075.6 Issued
NHLBI E-322-2007-0-FR-13 Compositions Containing Purine Nucleosides and Manganese and Their Uses FR EP 08835075.6 Issued
NHLBI E-322-2007-0-US-16 Compositions Containing Nucleosides and Manganese and Their Uses US CON 14/920,765 10342871 Issued PDF
NHLBI E-322-2007-0-AU-12 Compositions Containing Purine Nucleosides and Manganese and Their Uses AU DIV 2016222458 Issued
NHLBI E-322-2007-0-CA-10 Compositions Containing Purine Nucleosides and Manganese and Their Uses CA DIV 2926481 Issued
NHLBI E-322-2007-0-AU-08 Compositions Containing Purine Nucleosides and Manganese and Their Uses AU DIV 2014200523 Issued
NHLBI E-322-2007-0-CA-04 Compositions Containing Purine Nucleosides and Manganese and Their Uses CA National Stage 2695950 Issued
NHLBI E-322-2007-0-US-07 Compositions Containing Nucleosides and Manganese and Their Uses US National Stage 12/673,709 9186406 Issued PDF
NHLBI E-322-2007-0-AU-03 Compositions Containing Purine Nucleosides and Manganese and Their Uses AU National Stage 2008307308 Issued
NIA E-049-2001-0-DE-17 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF DE EP 08162544.4 Expired
NIA E-049-2001-0-FR-18 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF FR EP 08162544.4 Expired
NIA E-049-2001-0-GB-19 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF GB EP 08162544.4 Expired
NCI E-005-2002-0-US-05 Gene Expressed in Prostate Cancer and Methods of Use US CON 12/193,604 7897355 Abandoned PDF
NHLBI E-322-2007-0-PCT-02 Compositions Containing Purine Nucleosides and Manganese and Their Uses PCT PCT PCT/US08/073479 Expired
NCI E-237-2007-0-PCT-02 Hydrazide, Amide, Phthalimide and Phthalhydrazide Analogs as Inhibitors of Retroviral Integrase PCT PCT PCT/US2008/073511 Abandoned
NHLBI E-322-2007-0-US-17 Nucleosides Protect Against Irradiation And Other Stresses US CON 16/504,941 Abandoned
NHLBI E-322-2007-0-EP-05 Compositions Containing Purine Nucleosides and Manganese and Their Uses EP National Stage 08835075.6 Pending
NCI E-287-2009-0-US-01 ANTIPROLIFERATIVE FACTORS AND METHODS OF USE US 61/089,698 Abandoned
NIAID E-303-2008-0-US-01 Insect Salivary Proteins, Particularly Sand Fly Salivary Proteins Work As Non-classical Natural Adjuvants Driving A Specific Immune Response That Accelerate The Immune Response To Another Protein Or Pathogen US 61/089,884 Abandoned
NHLBI E-322-2007-0-JP-09 Compositions Containing Purine Nucleosides and Manganese and Their Uses JP DIV 2015-056355 Pending
NHLBI E-322-2007-0-JP-11 Compositions Containing Purine Nucleosides and Manganese and Their Uses JP DIV 2016-133367 Pending
NIAID E-142-1996-3-JP-15 PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES JP DIV 2008-184327 Abandoned